Oral care composition containing extract of unoxidized Camellia
AssigneeColgate-Palmolive Company
InventorsCortney Worrell, Harsh Trivedi, Kimberlee Panaligan, Tao Xu
Life of this patent
Estimating the term…
Abstract
An oral composition for at least one or treating and inhibiting an oral inflammatory condition comprising: a Camellia extract including at least about 30% epigallocatechin gallate, at least about 50% total catechins, and at least about 60% total polyphenols; and a substantially water insoluble non-cationic anti-bacterial agent.
Claims29
An oral composition for the treatment, inhibition or reduction of an oral inflammatory condition comprising:
- a Camellia extract including at least about 30% epigallocatechin gallate, at least about 50% total catechins, and at least about 60% total polyphenols;
- and
- a substantially water insoluble non-cationic anti-bacterial agent.
A method of at least one of treating and inhibiting an oral inflammatory condition comprising administering to an oral cavity of a subject in need thereof an effective amount of an oral composition comprising a Camellia extract including at least about 30% epigallocatechin gallate, at least about 50% total catechins, and at least about 60% total polyphenols.
An oral care composition comprising:
- Camellia extract;
- and
- at least about 0.001% by weight of Vitamin E.
A method of at least one of treating and inhibiting an oral inflammatory condition and providing antioxidant activity in an oral cavity by administering to an oral cavity of a human or other animal subject in need thereof an effective amount of an oral composition comprising:
- a Camellia extract including at least about 30% epigallocatechin gallate, at least about 50% total catechins, and at least about 60% total polyphenols;
- and
- a halogenated diphenyl ether anti-bacterial agent.
Dependencies are inferred from the claim text.